Executive Summary: The Combined Cost Pressure: What the Full Weight of These Drivers Means for a Small Group Level Funded Plan
LFP-09.SYN — The Cost Drivers#
The nine cost drivers documented in this series do not arrive in isolation. They converge on the same small risk pool, in the same plan year, through the same claims fund. When multiple drivers hit simultaneously, the combined pressure is compounding, not additive. The behavioral and chronic disease drivers amplify each other. High-cost acute events coincide with elevated baseline spending. The plan year that looked manageable in underwriting becomes catastrophic in experience. This synthesis models that convergence to establish what Series 10 must address.
The base case for a 20-person employer with typical demographics and no high-cost events produces $240,000 in expected annual claims at a specific attachment point of $60,000 and an aggregate attachment point of $300,000 (125 percent of expected). This is what the stop loss carrier prices for. The base case is not the problem.
In a moderate convergence scenario, nothing catastrophic occurs. One uncomplicated vaginal delivery adds $15,712, the Peterson-KFF commercial employer average. One GLP-1 prescription for diabetes adds approximately $9,250 in nine months below any specific attachment point. Two members with untreated depression amplify chronic disease costs by $16,000 to $24,000, consistent with Milliman’s $411 to $721 per member per month excess cost multiplier. Three members in physically demanding roles accumulate $12,000 to $24,000 in MSK imaging, injections, and PT. Total additional cost: $53,000 to $73,000 above the underwritten baseline. Expected claims of $240,000 become actual claims of $293,000 to $313,000. The aggregate attachment point is approached or breached. Ordinary convergence of moderate cost drivers, each common in working-age populations, transformed plan economics for the year.
In a severe convergence scenario, one complicated pregnancy with a 45-day NICU admission generates approximately $185,000 in claims. The specific stop loss absorbs $125,000 above the $60,000 deductible, but the deductible flows through the claims fund. A PCSK9 inhibitor, a GLP-1, two members with untreated depression generating $20,000 in excess medical costs, three members on MSK escalation trajectories, and one diabetic crossing the complication threshold with early nephropathy generating $35,000 to $45,000 in intensifying claims together add $88,000 to $98,000 above baseline. Total plan-paid claims reach approximately $388,000 to $398,000, breaching the aggregate attachment point by nearly $100,000. Both specific and aggregate stop loss activate. The plan year is still devastating. The renewal will be severe: lasers, rate increases, or nonrenewal.
The critical analytical point is that these cost drivers are not independent. Depression does not add to diabetes cost. It multiplies it, consistent with Milliman’s documented 2x to 3x excess spending multiplier for behavioral comorbidities. Obesity accelerates MSK progression. UnitedHealthcare documented MSK costs at $40.51 per member per month across its book; for employers with elevated obesity rates, the figure runs substantially higher. Social isolation, documented as carrying mortality risk comparable to smoking 15 cigarettes daily in the Holt-Lunstad meta-analysis, amplifies both depression and chronic disease non-adherence simultaneously. The severe convergence scenario, modeled by summing individual driver effects, understates the actual combined impact because the compounding operates across and within members simultaneously.
The magnitude of the combined threat justifies the cost management investment documented in Series 10. If the cost drivers were small and independent, managing them would produce marginal returns. Because they are large and compounding, managing them produces returns that redefine what small group level funded administration can deliver. A claims-processing TPA watches convergence happen. A cost-managing TPA changes the trajectory before it arrives. The cost drivers in this series are the evidence that the difference matters.